AMICUS THERAPEUTICS INC. - COMMON STOCK
10.09
14-November-24 16:45:00
15 minutes delayed
Stocks
-0.28
-2.70%
Today's range
10.06 - 10.43
ISIN
N/A
Source
NASDAQ
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
01 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
28 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
15 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
08 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
01 Feb 2024 07:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
07 Jan 2024 16:00:52 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK
28 Dec 2023 09:55:27 By NetDania Notify
-
NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK
27 Dec 2023 09:45:13 By NetDania Notify
-
NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK
26 Dec 2023 15:40:25 By NetDania Notify
-
05 Dec 2023 06:00:38 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
08 Nov 2023 07:00:01 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
01 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
27 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023
03 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
02 Oct 2023 08:20:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
28 Sep 2023 10:41:45 By Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
01 Sep 2023 07:00:18 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023
29 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
-
Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
21 Aug 2023 07:00:00 By Nasdaq GlobeNewswire